NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 237 filers reported holding NEKTAR THERAPEUTICS in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EARNEST PARTNERS LLC | 83 | $2,000 | 0.00% |
| Concord Wealth Partners | 50 | $1,000 | 0.00% |
| Private Capital Group, LLC | 67 | $1,000 | 0.00% |
| Smithfield Trust Co | 224 | $4,000 | 0.00% |
| COWEN AND COMPANY, LLC | 5,000 | $7,000 | 0.00% |
| COWEN AND COMPANY, LLC | 5,000 | $7,000 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 112,374 | $2,247,000 | 0.00% |
External links
This page lists NEKTAR THERAPEUTICS's shareholders in Q1 2021. To view NEKTAR THERAPEUTICS's shareholder history, click here.